On TRAIL for glioma therapy

作者: Josephus Marie André Kuijlen

DOI:

关键词:

摘要:

参考文章(156)
Patrizia Marini, Drug evaluation: lexatumumab, an intravenous human agonistic mAb targeting TRAIL receptor 2. Current Opinion in Molecular Therapeutics. ,vol. 8, pp. 539- ,(2006)
H Mellstedt, P Ragnhammar, I Magnusson, G Masucci, The therapeutic use of the unconjugated monoclonal antibodies (MAb) 17-1A in combination with GM-CSF in the treatment of colorectal carcinoma (CRC). Medical oncology and tumor pharmacotherapy. ,vol. 10, pp. 61- 70 ,(1993) , 10.1007/BF02987770
Henning Walczak, Robert E. Miller, Kiley Ariail, Brian Gliniak, Thomas S. Griffith, Marek Kubin, Wilson Chin, Jon Jones, Anne Woodward, Tiep Le, Craig Smith, Pam Smolak, Raymond G. Goodwin, Charles T. Rauch, JoAnn C.L. Schuh, David H. Lynch, Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo Nature Medicine. ,vol. 5, pp. 157- 163 ,(1999) , 10.1038/5517
Ludger Grosse-Hovest, Hans Georg Rammensee, Gundram Jung, Peter H. Krammer, Target cell-restricted triggering of the CD95 (APO-1/Fas) death receptor with bispecific antibody fragments. Cancer Research. ,vol. 61, pp. 1846- 1848 ,(2001)
Yoshihiro Hayakawa, Valentina Screpanti, Hideo Yagita, Alf Grandien, Hans-Gustaf Ljunggren, Mark J. Smyth, Benedict J. Chambers, NK Cell TRAIL Eliminates Immature Dendritic Cells In Vivo and Limits Dendritic Cell Vaccination Efficacy The Journal of Immunology. ,vol. 172, pp. 123- 129 ,(2004) , 10.4049/JIMMUNOL.172.1.123
Tatsuhiro Joki, Marcelle Machluf, Anthony Atala, Jianhong Zhu, Nicholas T. Seyfried, Ian F. Dunn, Toshiaki Abe, Rona S. Carroll, Peter McL. Black, Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. Nature Biotechnology. ,vol. 19, pp. 35- 39 ,(2001) , 10.1038/83481
Lars E. French, Jürg Tschopp, The TRAIL to selective tumor death Nature Medicine. ,vol. 5, pp. 146- 147 ,(1999) , 10.1038/5505
Günter J. Hämmerling, Peter Möller, Gerhard Moldenhauer, Frank Momburg, Frank Momburg, Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Research. ,vol. 47, pp. 2883- 2891 ,(1987)
Minji Jo, Tae-Hyoung Kim, Dai-Wu Seol, James E. Esplen, Kenneth Dorko, Timothy R. Billiar, Stephen C. Strom, Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand Nature Medicine. ,vol. 6, pp. 564- 567 ,(2000) , 10.1038/75045
Jan Dörr, Ingo Bechmann, Sonia Waiczies, Orhan Aktas, Henning Walczak, Peter H. Krammer, Robert Nitsch, Frauke Zipp, Lack of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand But Presence of Its Receptors in the Human Brain The Journal of Neuroscience. ,vol. 22, ,(2002) , 10.1523/JNEUROSCI.22-04-J0001.2002